The role of 18F‐FDG‐PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients

Sung Hoon Yang, Kyung‐Suk Suh, Hae Won Lee, Eung‐Ho Cho, Jai Young Cho, Yong Beom Cho, Nam‐Joon Yi, Kuhn Uk Lee – 8 September 2006 – Positron emission tomography (PET) using F‐18 fluoro‐2‐deoxy‐d‐glucose (18F‐FDG) is now well established as a noninvasive diagnostic tool for the detection of a variety of malignant tumors. However, in the case of hepatocellular carcinoma (HCC), several investigators have reported controversial conclusions and an inadequate sensitivity for PET (50‐55%).

Impact of UCSF criteria according to pre‐ and post‐OLT tumor features: Analysis of 479 patients listed for HCC with a short waiting time

Thomas Decaens, Françoise Roudot‐Thoraval, Solange Hadni‐Bresson, Carole Meyer, Jean Gugenheim, Francois Durand, Pierre‐Henri Bernard, Olivier Boillot, Laurent Sulpice, Yvon Calmus, Jean Hardwigsen, Christian Ducerf, Georges‐Philippe Pageaux, Sebastien Dharancy, Olivier Chazouilleres, Daniel Cherqui, Christophe Duvoux – 8 September 2006 – Orthotopic liver transplantation (OLT) indication for hepatocellular carcinoma (HCC) is currently based on the Milan criteria.

Subscribe to